The gut microbiome is essential for maintaining gastrointestinal (GI) barrier integrity. For example, beneficial bacteria produce short-chain fatty acids (SCFAs), such as butyrate, which support epithelial barrier function and help reduce inflammation3.
The microbiota: our invisible health allies
The gut microbiota is a vast and dynamic ecosystem of microorganisms living in our digestive tract. Weighing up to 2 kg, this diverse community includes trillions of bacteria, viruses, fungi, and archaea, which collectively contain over three million microbial genes—significantly outnumbering human genes. Far from being passive inhabitants, these microbes play a key role in maintaining overall health, extending well beyond digestion.
Key functions of the human gut microbiota
This microbial ecosystem interacts continuously with the body, performing essential functions such as:
- Breaking down complex food components, particularly dietary fiber, which the body cannot digest on its own.
- Synthesizing essential vitamins, including vitamin B12, folate, and vitamin K, which contribute to blood clotting and nervous system health.
- Regulating energy metabolism, influencing weight, insulin sensitivity, and overall metabolic balance.
- Providing a first line of defense against harmful microbes, helping to reduce the risk of infections and inflammatory diseases.
- Training and modulating the immune system, shaping the body’s response to pathogens and external threats.
Every microbiome is unique
Much like a fingerprint, the composition of the gut microbiota is unique to each person. While 10% of microbial species are shared among all humans, the rest varies based on genetics, lifestyle, and environmental factors.
Several key elements influence the diversity and composition of the intestinal microbiome:
- Genetics: inherited traits can influence microbial stability and resilience.
- Birth mode: babies born vaginally receive beneficial microbes from their mother, while those delivered via C-section may develop a different bacterial composition.
- Age: the microbiota evolves from infancy to old age, adapting to changing dietary and environmental exposures.
- Lifestyle and environment: factors like pollution, antibiotic use, and daily habits can alter bacterial diversity.
- Diet: one of the most significant influencers, as food choices directly impact microbial balance and gut health.
While genetics set the foundation, up to 60% of the microbiome can be shaped by lifestyle choices. This adaptability means that targeted dietary and lifestyle interventions can actively improve gut health, paving the way for personalized approaches to well-being.
10%
of microbial species are shared among all humans
60%
of the microbiome can be shaped by lifestyle choices
The first 1000 days: a critical period for microbiome development
The first 1000 days of life —from conception to a child’s second birthday—are a pivotal window for gut microbiota establishment1. Several factors have been shown to support healthy microbiome development during this phase:
- Vaginal birth, which allows early colonization by maternal microbes.
- Breastfeeding, providing essential nutrients and beneficial bacteria to strengthen gut health.
- Maternal diet and microbiota health, influencing the baby’s microbial diversity even before birth.
- Exposure to natural environments, as contact with diverse microbes in nature supports immune system maturation.
Scientific studies suggest that a well-balanced gut microbiota in early life can reduce the risk of long-term health issues, including asthma, allergies, obesity, and even neurodevelopmental conditions. Understanding these early influences opens new possibilities for preventive health strategies, emphasizing the role of nutrition and environment in shaping lifelong well-being.
Now that we've learned about the role and function of the gut microbiota, let's turn our attention to a key player in the relationship between these microorganisms and the rest of the body.
The intestinal barrier: a key regulator of gut-organ interactions
Composed of intestinal epithelial cell, mucus layers, and immune components, this barrier prevents harmful substances from leaking into the bloodstream while allowing the absorption of essential nutrients. It plays a vital role in maintaining gut homeostasis and regulating interactions between the gut microbiota and other organs.
A healthy barrier acts as a selective gatekeeper, but when compromised, it can lead to increased intestinal permeability—commonly referred to as "leaky gut"2. This disruption allows metabolites, toxins, and inflammatory molecules to enter circulation, contributing to systemic inflammation and organ dysfunction.
The gut-organ axis and dysbiosis: the consequences of microbiome imbalance
Balance between the gut and the body's other organs relies on a diverse microbiome to support digestion, intestinal barrier function, metabolism, immune regulation, and communication with other organs. When this delicate equilibrium is disrupted a cascade of health issues can emerge, affecting not only the gastrointestinal system but also metabolic, immune, and neurological functions. Thus, dysbiosis has been linked to chronic inflammation, metabolic disorders, and increased susceptibility to disease4.
Immune dysfunction and chronic inflammation
One of the most immediate consequences of gut dysbiosis is immune system dysfunction. The gut microbiota plays a fundamental role in training the immune system, helping it distinguish between harmless antigens and potential threats. However, when harmful bacteria overpopulate the gut, they can trigger chronic low-grade inflammation, contributing to the development of autoimmune and inflammatory diseases4.
- Inflammatory bowel disease (IBD): imbalances in gut bacteria have been associated with Crohn’s disease and ulcerative colitis, leading to excessive immune activation and tissue damage in the intestines.
- Autoimmune disorders: emerging research suggests that gut dysbiosis may be a contributing factor in conditions such as rheumatoid arthritis and multiple sclerosis, as alterations in microbial composition influence immune regulation and inflammation levels.
- Allergic reactions: a disrupted gut microbiome has been linked to heightened allergic responses and food intolerances, likely due to an impaired ability to regulate immune sensitivity.
Metabolic disorders
Beyond immune regulation, gut microbiota dysbiosis plays a significant role in metabolic health. Imbalances can disrupt nutrient metabolism, insulin signaling, and fat storage, leading to an increased risk of obesity, type 2 diabetes, and metabolic syndrome.
- Obesity: studies suggest that individuals with obesity may have a lower microbial diversity, with an overrepresentation of bacteria that extract more energy from food, leading to increased fat accumulation.
- Type 2 Diabetes: gut dysbiosis has been associated with insulin resistance, as certain bacterial byproducts can induce low-grade inflammation, impairing glucose metabolism.
- Metabolic syndrome: a cluster of conditions—including hypertension, high blood sugar, and excess visceral fat—has been linked to altered gut microbiota composition, highlighting the role of microbial metabolites in metabolic regulation.
Dysbiosis and the gut-brain connection
The impact of gut dysbiosis extends beyond the immune and metabolic systems, influencing mental health and cognitive function. Alterations in gut microbiota can lead to increased stress, anxiety, and depression, as microbial imbalances affect the production of neurotransmitters such as serotonin and dopamine. Furthermore, dysbiosis-induced inflammation has been implicated in neurodegenerative disorders, including Alzheimer’s and Parkinson’s disease3.
Key insights on the gut-organ axes and microbiome interventions
The intestinal microbiome maintains bidirectional connections with multiple organs, influencing their function and revealing innovative therapeutic and nutritional approaches.
Key axes and health implications
Here are a few of the proven avenues currently under investigation.
Gut-liver axis
Fecal microbiota transplantation (FMT), targeted probiotics & high-fiber, low-processed food diets
FMT and probiotic strains like Lactobacillus help rebalance gut microbiota in liver cirrhosis, reducing ammonia production and slowing fibrosis progression. These approaches restore microbial diversity, which is critical for detoxification and reducing hepatic inflammation.
On the other hand, prioritizing fiber-rich foods (whole grains, legumes) and minimizing ultra-processed items strengthens the gut barrier, preventing bacterial endotoxins (e.g., LPS) from leaking into the bloodstream and triggering liver damage. This directly lowers oxidative stress in hepatocytes.
Prebiotics and SCFA optimization
Prebiotics (inulin, resistant starch) fuel gut bacteria that produce short-chain fatty acids (SCFAs) like butyrate. Butyrate suppresses pro-inflammatory cytokines (e.g., TNF-α) and enhances liver regeneration, offering protection against NAFLD and alcoholic hepatitis.
Restoring microbial balance through probiotics, diet, and prebiotics disrupts the "gut-liver loop" of inflammation, addressing root causes of liver disease rather than just symptoms.
Gut-heart axis
Polyphenol-rich diets and fiber optimization
Green tea, berries, flaxseeds, and whole grains inhibit TMAO-producing gut bacteria (Clostridium sporogenes), slashing cardiovascular risk. Fiber also supports SCFA-producing microbes, which lower systemic inflammation and stabilize blood pressure.
Targeted probiotic strains
Lactobacillus reuteri and Bifidobacterium longum metabolize bile acids, reducing LDL cholesterol. These strains also produce bioactive peptides that relax blood vessels, improving endothelial function.
Dietary patterns and microbial diversity
Mediterranean-style diets (olive oil, fatty fish, nuts) boost Akkermansia and Roseburia species, which enhance nitric oxide production and reduce arterial stiffness. Avoiding high-fat dairy and processed meats minimizes LPS leakage, a driver of atherosclerosis.
Probiotics plus prebiotics synergize to modulate the gut-heart axis, optimizing microbial metabolites (SCFAs, nitric oxide) while suppressing harmful compounds (TMAO, LPS). This dual action tackles inflammation and vascular dysfunction at their source.
Gut-lung axis
Probiotics and immune modulation
Strains like Lactobacillus rhamnosus and Bifidobacterium breve enhance respiratory immunity by activating dendritic cells and T-regulatory cells, reducing airway hyperreactivity in asthma and COPD. These probiotics lower pro-inflammatory cytokines (IL-6, IL-17) linked to chronic lung inflammation.
Fermented foods and antiviral defense
Kefir, kimchi, and miso increase gut microbial diversity, boosting Akkermansia muciniphila and Faecalibacterium prausnitzii. These bacteria improve antiviral responses against respiratory viruses (e.g., influenza, SARS-CoV-2).
Fiber-rich diets and barrier integrity
Prebiotic fibers (beta-glucans, inulin) fuel SCFA-producing bacteria, which tighten gut-lung barrier function. This reduces systemic endotoxin (LPS) leakage, preventing "cytokine storms" and alveolar damage during severe infections.
Probiotics and fermented foods synergize to balance microbial communities, which "trains" lung-resident immune cells (macrophages, mast cells) via the gut-lung axis. This cross-talk minimizes inflammation while priming antiviral defenses, offering dual protection against chronic and infectious respiratory diseases.
Gut-kidney axis
Plant-based protein prioritization
Shifting to plant proteins (legumes, quinoa) over red/processed meats reduces nitrogenous waste (e.g., urea, ammonia), easing the kidney’s detoxification load. This lowers uremic toxin buildup linked to chronic kidney disease (CKD) progression.
SCFA boost via high-fiber diets
Fiber-rich foods (oats, flaxseeds) feed gut bacteria that produce SCFAs like butyrate and acetate. These metabolites suppress renal inflammation and reducing oxidative stress, protecting against glomerular damage.
Prebiotic/probiotic synergy
Prebiotics (inulin, FOS) combined with probiotics (Lactobacillus plantarum, Bifidobacterium infantis) enhance gut barrier integrity, limiting bacterial endotoxin (LPS) leakage into the bloodstream. This prevents systemic inflammation that exacerbates diabetic nephropathy and CKD.
Reducing animal protein intake and increasing fiber/prebiotics disrupts the "gut-kidney crosstalk" of uremic toxins and inflammation, while SCFAs directly protect renal tissues. This dual approach slows CKD progression and improves dialysis outcomes.
Gut-skin axis
Oral probiotics and gut-skin axis modulation
Oral Bifidobacterium longum and Lactobacillus strains reduce systemic inflammation by lowering pro-inflammatory cytokines and sebum overproduction. This improves acne severity and skin hydration via ceramide synthesis.
Prebiotics (Inulin/FOS) and barrier reinforcement
Inulin from chicory root (FOS) feeds commensal bacteria like Akkermansia, increasing SCFA production to strengthen tight junctions and reduce transepidermal water loss. This calms oxidative stress and prevents irritants from disrupting the microbiome, making it ideal for acne-prone and sensitive skin.
Prebiotics (inulin/FOS) act as “fertilizer” for probiotics (Bifidobacterium, Lactobacillus), amplifying their anti-inflammatory and antimicrobial effects. This synergy enhances skin barrier resilience while rebalancing both gut and skin microbiomes, addressing acne at its root.
Gut-brain axis
Prebiotic, probiotic and synbiotic formulations
Building on our pioneering work with prebiotics , we have developed synbiotic mixtures that combine their scGOS/lcFOS prebiotic blend with specific probiotic strains like Bifidobacterium breve M-16V. These formulations aim to provide comprehensive support for gut health and, by extension, brain health.
Fermentation technologies
Our unique Lactofidus™ fermentation process involves fermenting milk with specific bacteria and then heat-treating the product to retain beneficial metabolites. This process has been shown to improve digestibility and tolerance, potentially supporting both gut and brain health.
Biomimetic innovations
Drawing inspiration from nature, Danone has developed Nuturis, a trademarked milk phospholipid-coated lipid droplet that mimics the structure of human milk fat globules. This innovation aims to provide benefits similar to those observed in breastfed infants, potentially supporting optimal gut-brain development.
3 key cross-cutting strategies for microbiome health
Probiotics/prebiotics for dysbiosis & metabolite pptimization
Targeted probiotics (Lactobacillus, Bifidobacterium) and prebiotics (inulin, FOS) restore microbial balance, boosting SCFAs (butyrate), antioxidants, and bacteriocins. These metabolites strengthen gut-organ axes (gut-liver, gut-heart) and reduce systemic inflammation. For example, synbiotic blends (e.g., B. longum + inulin) enhance gut barrier integrity while lowering LPS leakage.
Dietary modifications for microbial diversity
Prioritizing 30g daily fiber or more via whole grains, legumes and fermented foods diversifies microbiota, while cutting processed additives and saturated fats reduces harmful bacteria overgrowth. Mediterranean or plant-forward diets amplify specific strains that improve metabolic and immune resilience.
Emerging therapies beyond FMT
While fecal microbiota transplantation (FMT) remains gold-standard for C. difficile, next-gen therapies—engineered probiotics (e.g., E. coli Nissle), phage therapy, and microbial consortia—are being tested for obesity, NAFLD, and autoimmune diseases.
Combining these strategies creates a multi-targeted approach: dietary shifts feed beneficial microbes, probiotics/prebiotics amplify their activity, and advanced therapies address deep dysbiosis. This integrated model underscores the microbiome’s role as a central modulator of health, paving the way for precision nutrition and microbiome-based medicine.
- Tamburini S, Shen N, Wu HC, Clemente JC. The microbiome in early life: implications for health outcomes. Nat Med. 2016 Jul 7;22(7):713-22. doi: 10.1038/nm.4142. PMID: 27387886.
- Ahlawat S, Asha, Sharma KK. Gut-organ axis: a microbial outreach and networking. Lett Appl Microbiol. 2021 Jun;72(6):636-668. doi: 10.1111/lam.13333. Epub 2020 Jul 16. PMID: 32472555.
- Guo Y, Chen X, Gong P, Li G, Yao W, Yang W. The Gut-Organ-Axis Concept: Advances the Application of Gut-on-Chip Technology. Int J Mol Sci. 2023 Feb 17;24(4):4089. doi: 10.3390/ijms24044089. PMID: 36835499; PMCID: PMC9962350.
- Saxami, G.; Kerezoudi, E.N.; Eliopoulos, C.; Arapoglou, D.; Kyriacou, A. The Gut–Organ Axis within the Human Body: Gut Dysbiosis and the Role of Prebiotics. Life 2023, 13, 2023. https://doi.org/10.3390/life13102023
- Sampson TR, Debelius JW, Thron T, Janssen S, Shastri GG, Ilhan ZE, Challis C, Schretter CE, Rocha S, Gradinaru V, Chesselet MF, Keshavarzian A, Shannon KM, Krajmalnik-Brown R, Wittung-Stafshede P, Knight R, Mazmanian SK. Gut Microbiota Regulate Motor Deficits and Neuroinflammation in a Model of Parkinson's Disease. Cell. 2016 Dec 1;167(6):1469-1480.e12. doi: 10.1016/j.cell.2016.11.018. PMID: 27912057; PMCID: PMC5718049.
- Nie Hong-Yun , Ge Jun , Huang Guo-Xing , Liu Kai-Ge , Yue Yuan , Li Hao , Lin Hai-Guan , Zhang Tao , Yan Hong-Feng , Xu Bing-Xin , Sun Hong-Wei , Yang Jian-Wu , Si Shao-Yan , Zhou Jin-Lian , Cui Yan. New insights into the intestinal barrier through “gut-organ” axes and a glimpse of the microgravity’s effects on intestinal barrier. Frontiers in Physiology 15-2024. DOI=10.3389/fphys.2024.1465649. ISSN=1664-042X
- Naoto Fukasawa, Junya Tsunoda, Shogo Sunaga, Hiroki Kiyohara, Nobuhiro Nakamoto, Toshiaki Teratani, Yohei Mikami, Takanori Kanai, The gut–organ axis: Clinical aspects and immune mechanisms, Allergology International, 2025, ISSN 1323-8930
